Deep-brain stimulation for Parkinson's disease [1]

New England Journal of Medicine

Volumn 363, Issue 10, 2010, Pages 987-988

  Escamilla Sevilla, Francisco ^a   Minguez Castellanos, Adolfo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BRAIN DEPTH STIMULATION; COGNITION; DYSKINESIA; HUMAN; LETTER; MOOD; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; ELECTROSTIMULATION THERAPY; GLOBUS PALLIDUS; METHODOLOGY; MULTIVARIATE ANALYSIS; NOTE; SUBTHALAMIC NUCLEUS; WEIGHT GAIN; DEPRESSION; PSYCHOLOGICAL ASPECT;

ELECTRIC STIMULATION THERAPY; GLOBUS PALLIDUS; HUMANS; MULTIVARIATE ANALYSIS; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; WEIGHT GAIN; DEPRESSION; DOPAMINE AGENTS; LEVODOPA;

LEVODOPA; PRAMIPEXOLE; DOPAMINE RECEPTOR STIMULATING AGENT;

EID: 77956270219     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1007650     Document Type: Letter

References (5)

1. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-91.
2. Minguez-Castellanos A, Escamilla-Sevilla F, Katati MJ, et al. Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target-related effect or selection bias? J Neurol Neurosurg Psychiatry 2005;76:34-9.
3. Minguez-Castellanos A, Escamilla-Sevilla F. Pallidal vs. subthalamic deep brain stimulation for Parkinson disease: winner and loser or a sharing of honors? Arch Neurol 2005;62:1642-3.
4. Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010;133:1111-27.
5. Escamilla-Sevilla F, Munoz-Pasadas M, Perez-Navarro MJ, et al. Disruption of the melanocortin system caused by bilateral subthalamic nucleus stimulation in Parkinson's disease. Mov Disord 2009;24:Suppl 1:S462-S463.